# A 10 Week Open-Label Pilot Study to Evaluate the Effectiveness and Safety of Memantine(Namenda) as Augmentation Therapy in Patients With Generalized Anxiety Disorder

> **NCT00411398** · PHASE3 · COMPLETED · sponsor: **State University of New York - Upstate Medical University** · enrollment: 15 (actual)

## Conditions studied

- General Anxiety Disorder, Social Anxiety Disorder

## Interventions

- **DRUG:** Namenda/Memantine

## Key facts

- **NCT ID:** NCT00411398
- **Lead sponsor:** State University of New York - Upstate Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-12
- **Primary completion:** 2010-05
- **Final completion:** 2010-05
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2014-12-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00411398

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00411398, "A 10 Week Open-Label Pilot Study to Evaluate the Effectiveness and Safety of Memantine(Namenda) as Augmentation Therapy in Patients With Generalized Anxiety Disorder". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00411398. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*